Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 0363-9946

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 0363-9946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walgreen Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg/60 mg (18 Tablet Carton Label))

Package Label-principal Display Panel (600 mg/60 mg (18 Tablet Carton Label))
This is a description of a medicine in an extended-release tablet form. It contains Guaifenesin USP 600 mg as an expectorant and Pseudoephedrine HCI USP 60 mg as a nasal decongestant. The medicine claims to clear both nasal and sinus congestion, and also help thin and loosen mucus. The tablet provides relief for 12 hours. There is a batch coding area on the box.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.